Summary
The effect of pyridoxine hydrochloride, 200 mg/day (0.97 mmol/day) for 3 weeks, upon plasma and urinary oxalate has been determined in ten normal subjects and seven patients with idiopathic hypercalciuria while both groups were on low-oxalate diets. Patients had higher basal urinary oxalate levels than normal subjects. In normal subjects pyridoxine administration decreased plasma oxalate levels and raised urinary oxalate. The patients showed no change in either plasma or urinary oxalate.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Backman U (1976) Kidney function during hydropenia and water diuresis n patients with idiopathic recurring nephrolithiasis. Scand J Urol Nephrol 10:243–251
Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E (1982) Effect of vitamin B6 administration on elevated plasma oxalate acid levels in haemodialysed patients. Eur J Clin Invest 12:461–483
Cohanim M, Yendt ER (1980) Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis. Invest Urol 18:170–172
Edwards P, Liu PKS, Rose GA (1989) A simple liquid-chromatographic method for measuring vitamin B6 compounds in plasma. Clin Chem 35:241–245
Faber SR, Feitler WW, Bleiler RE, Ohlson MA, Hodges RE (1963) The effects of an induced pyridoxine and pantothenic acid deficiency on excretions of oxalic and xanthurenic acids in the urine. Am J Clin Nutr 12:406–412
Gershoff SN, Faragalla FF, Nelson DA, and Andrus SB (1959) Vitamin B6 deficiency oxalate nephrocalcinosis in the cat. Am J Med 27:72–80
Gill HS, Rose GA (1985) Idiopathic hypercalciuria. Urol Res 13:271–275
Hallson PC, Kasidas GP, Rose GA (1976) Urinary oxalate in summer and winter in normal subjects and in stone forming patients in idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate. Urol Res 4:169–173
Hesse A, Bach D (1982) Harnsteine pathobiochemie und klinisch-chemische Diagnostik. Thieme, Stuttgart New York, pp 37–38
Hodgkinson A (1978) Evidence of increased absorption in patients with calcium-containing renal stones. Clin Sci Mol Med 54:291–294
Kasidas GP, Rose GA (1979) A new enzymatic method for the determination of glycollate in urine and plasma. Clin Chim Acta 96:25–36
Kasidas GP, Rose GA (1985) Continuous-flow assay for urinary oxalate using immobilised oxalate oxidase. Ann Clin Biochem 22:412–419
Kasidas GP, Rose GA (1986) Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta 154:49–58
Kasidas GP, Rose GA (1989) Circadian variation of plasma oxalate in normal healthy subjects. In: Walker VR, Sutton RA, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, pp 539–541
Lau YK, Wasserstein A, Westby GR, Bosanac CP, Grabie M, Mitnick P, Slatopolsky E, Goldfarb S, Agus ZS (1982) Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration. Miner Electrolyte Metab 7:237–249
Lindsjo M, Fellstrom B, Danielson BOG, Kasidas GP, Rose GA, Ljunghall S (1989) Hyperoxaluria or hypercalciuria in nephrolithiasis—the importance of renal tubular functions. Scand J Urol Nephrol IV [Suppl 119]:1–23
Morgan SH, Maher ER, Purkiss P, Watts RWE, Curtis JR (1988) Oxalate metabolism in ends-stage renal disease: the effect of ascorbic acid and pyridoxine. Nephrol Dial Transplant 3:28–32
Nakada T, Sasagawa I, Furuta K, Katayama T, Shimazaki J (1988) Effect of high calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol 15:264–270
Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110
Smith LH, Williams HE (1967) Treatment of primary hyperoxaluria. Mod Treat 4:522–530
Tiselius H-G (1980) Oxalate and renal stone formation. Scand J Urol Nephrol [Suppl] 53:135–146
Tiselius HG, Almgard LE (1977) The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate an oxalate excretion. Eur Urol 3:41–46
Thomson CRV, Channon Susan M, Parkinson IS, Sheldon WS, Ward MK, Laker MK (1989) Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis. Eur J Clin Invest 19:201–205
Zarembski PM, Hodgkinson A (1969) Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta 25:1–10
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edwards, P., Nemat, S. & Rose, G.A. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria. Urol. Res. 18, 393–396 (1990). https://doi.org/10.1007/BF00297371
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00297371